Laura Naranjo

IL-6–based mortality risk model for hospitalized patients with COVID-19

Rocío Laguna‐Goya, Alberto Utrero‐Rico, Paloma Talayero et al. · Journal of Allergy and Clinical Immunology · 2020 · 228 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +15

T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression

Francisco Javier Gil‐Etayo, Patricia Suàrez-Fernández, Óscar Cabrera-Marante et al. · Frontiers in Cellular and Infection Microbiology · 2021 · 163 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome

Mar Guasp, Guillermo Muñoz‐Sánchez, Eugenia Martínez‐Hernández et al. · Frontiers in Immunology · 2022 · 103 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +17

Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis

Raquel Ruiz‐García, Guillermo Muñoz‐Sánchez, Laura Naranjo et al. · Frontiers in Immunology · 2021 · 87 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

Mar Guasp, Mireia Rosa-Justícia, Amaia Muñoz‐Lopetegi et al. · The Lancet Neurology · 2022 · 86 citations

Medicine, Neurology, Neuroscience +7